scholarly journals Charting cellular identity during human in vitro β-cell differentiation

Nature ◽  
2019 ◽  
Vol 569 (7756) ◽  
pp. 368-373 ◽  
Author(s):  
Adrian Veres ◽  
Aubrey L. Faust ◽  
Henry L. Bushnell ◽  
Elise N. Engquist ◽  
Jennifer Hyoje-Ryu Kenty ◽  
...  
2007 ◽  
Vol 38 (2) ◽  
pp. 193-206 ◽  
Author(s):  
Amanda M Ackermann ◽  
Maureen Gannon

Pancreatic β-cells are responsible for producing all of the insulin required by an organism to maintain glucose homeostasis. Defects in development, maintenance, or expansion of β-cell mass can result in impaired glucose metabolism and diabetes. Thus, identifying the molecular regulators of these processes may provide new therapeutic targets for diabetes. Additionally, understanding the processes of β-cell differentiation and proliferation may allow for in vitro cultivation of β-cells in sufficient amounts to be transplanted into patients with diabetes. This review addresses many of the transcription factors and signaling pathways that play a role in early pancreatic development and endocrine cell (specifically β-cell) differentiation, conditions that influence β-cell mass development and molecular regulators of β-cell proliferation and apoptosis that are responsible for maintaining and expanding β-cell mass.


Cell Reports ◽  
2020 ◽  
Vol 31 (8) ◽  
pp. 107687 ◽  
Author(s):  
Leonardo Velazco-Cruz ◽  
Madeleine M. Goedegebuure ◽  
Kristina G. Maxwell ◽  
Punn Augsornworawat ◽  
Nathaniel J. Hogrebe ◽  
...  

2014 ◽  
Vol 16 (6) ◽  
pp. 456-466 ◽  
Author(s):  
Elisa Corritore ◽  
Erica Dugnani ◽  
Valentina Pasquale ◽  
Ryosuke Misawa ◽  
Piotr Witkowski ◽  
...  

2001 ◽  
Vol 15 (3) ◽  
pp. 476-483 ◽  
Author(s):  
Dominique Dufayet de la Tour ◽  
Tanya Halvorsen ◽  
Carla Demeterco ◽  
Björn Tyrberg ◽  
Pamela Itkin-Ansari ◽  
...  

Abstract Cell transplantation therapy for diabetes is limited by an inadequate supply of cells exhibiting glucose-responsive insulin secretion. To generate an unlimited supply of human β-cells, inducibly transformed pancreatic β-cell lines have been created by expression of dominant oncogenes. The cell lines grow indefinitely but lose differentiated function. Induction of β-cell differentiation was achieved by stimulating the signaling pathways downstream of the transcription factor PDX-1, cell-cell contact, and the glucagon-like peptide (GLP-1) receptor. Synergistic activation of those pathways resulted in differentiation into functional β-cells exhibiting glucose-responsive insulin secretion in vitro. Both oncogene-expressing and oncogene-deleted cells were transplanted into nude mice and found to exhibit glucose-responsive insulin secretion in vivo. The ability to grow unlimited quantities of human β-cells is a major step toward developing a cell transplantation therapy for diabetes.


2009 ◽  
Vol 390 (10) ◽  
Author(s):  
Luc Baeyens ◽  
Luc Bouwens

Abstract Cell replacement therapy holds promises for treatment of patients suffering from diabetes mellitus. When determining the appropriate strategies to amplify the amount of transplantable β-cells, sufficient knowledge of the developmental programs regulating β-cell differentiation is crucial. Here, we describe the plasticity of the different pancreatic cell types in vivo and in vitro and their potential to serve as β-cell progenitor.


Stem Cells ◽  
2007 ◽  
Vol 25 (12) ◽  
pp. 3155-3164 ◽  
Author(s):  
Christopher A. Fraker ◽  
Silvia Álvarez ◽  
Panagiotis Papadopoulos ◽  
Jaime Giraldo ◽  
Weiyong Gu ◽  
...  
Keyword(s):  

Cells ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 413 ◽  
Author(s):  
Galli Alessandra ◽  
Marku Algerta ◽  
Marciani Paola ◽  
Schulte Carsten ◽  
Lenardi Cristina ◽  
...  

Embryonic and pluripotent stem cells hold great promise in generating β-cells for both replacing medicine and novel therapeutic discoveries in diabetes mellitus. However, their differentiation in vitro is still inefficient, and functional studies reveal that most of these β-like cells still fail to fully mirror the adult β-cell physiology. For their proper growth and functioning, β-cells require a very specific environment, the islet niche, which provides a myriad of chemical and physical signals. While the nature and effects of chemical stimuli have been widely characterized, less is known about the mechanical signals. We here review the current status of knowledge of biophysical cues provided by the niche where β-cells normally live and differentiate, and we underline the possible machinery designated for mechanotransduction in β-cells. Although the regulatory mechanisms remain poorly understood, the analysis reveals that β-cells are equipped with all mechanosensors and signaling proteins actively involved in mechanotransduction in other cell types, and they respond to mechanical cues by changing their behavior. By engineering microenvironments mirroring the biophysical niche properties it is possible to elucidate the β-cell mechanotransductive-regulatory mechanisms and to harness them for the promotion of β-cell differentiation capacity in vitro.


Sign in / Sign up

Export Citation Format

Share Document